Cliff Asness's AMRX Position Overview
Cliff Asness (via Aqr Capital Management LLC) currently holds 864,792 shares of Amneal Pharmaceuticals, Inc. (AMRX) worth $10.75 M, representing 0.00% of the portfolio. First purchased in 2018-Q2, this medium-term investment has been held for 19 quarters.
Based on 13F filings, Cliff Asness has maintained a strategic position in AMRX, demonstrating sustained confidence in this investment. Largest addition occurred in Q4 2022, adding 1.16 M shares. Largest reduction occurred in Q3 2023, reducing 1.22 M shares.
Analysis based on 13F filings available since 2013 Q2
Cliff Asness's Amneal Pharmaceuticals (AMRX) Holding Value Over Time
Track share changes against reported price movement
Quarterly Amneal Pharmaceuticals (AMRX) Trades by Cliff Asness
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | -181,320 | Reduce 17.33% | 864,792 | $12.43 |
| Q4 2025 | +32,096 | Add 3.17% | 1.05 M | $12.60 |
| Q3 2025 | -5,089 | Reduce 0.50% | 1.01 M | $10.01 |
| Q2 2025 | +273,630 | Add 36.71% | 1.02 M | $8.09 |
| Q1 2025 | +408,677 | Add 121.34% | 745,475 | $8.38 |
| Q4 2024 | +33,545 | Add 11.06% | 336,798 | $7.92 |
| Q3 2024 | -131,829 | Reduce 30.30% | 303,253 | $8.32 |
| Q2 2024 | -321,305 | Reduce 42.48% | 435,082 | $6.35 |
| Q1 2024 | -72,362 | Reduce 8.73% | 756,387 | $6.06 |
| Q4 2023 | -110,897 | Reduce 11.80% | 828,749 | $6.07 |
| Q3 2023 | -1.22 M | Reduce 56.42% | 939,646 | $4.22 |
| Q2 2023 | -854,660 | Reduce 28.39% | 2.16 M | $3.10 |
| Q1 2023 | +874,650 | Add 40.94% | 3.01 M | $1.39 |
| Q4 2022 | +1.16 M | Add 119.74% | 2.14 M | $1.99 |
| Q3 2022 | +679,824 | Add 232.55% | 972,161 | $2.02 |
| Q2 2022 | +55,339 | Add 23.35% | 292,337 | $3.18 |
| Q1 2022 | +236,998 | New Buy | 236,998 | $4.17 |
| Q3 2018 | -41,041 | Sold Out | 0 | $0.00 |
| Q2 2018 | +41,041 | New Buy | 41,041 | $16.40 |
Cliff Asness's Amneal Pharmaceuticals Investment FAQs
Cliff Asness first purchased Amneal Pharmaceuticals, Inc. (AMRX) in Q2 2018, acquiring 41,041 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Cliff Asness has held Amneal Pharmaceuticals, Inc. (AMRX) for 19 quarters since Q2 2018.
Cliff Asness's largest addition to Amneal Pharmaceuticals, Inc. (AMRX) was in Q4 2022, adding 2,136,252 shares worth $4.25 M.
According to the latest 13F filing for Q1 2026, Cliff Asness's firm, Aqr Capital Management LLC, owns 864,792 shares of Amneal Pharmaceuticals, Inc. (AMRX), valued at approximately $10.75 M.
As of the Q1 2026 filing, Amneal Pharmaceuticals, Inc. (AMRX) represents approximately 0.00% of Cliff Asness's publicly disclosed stock portfolio, making it one of their key holdings.
Cliff Asness's peak holding in Amneal Pharmaceuticals, Inc. (AMRX) was 3,010,902 shares, as reported at the end of Q1 2023.